Tuberculosis and Respiratory Diseases

  • 제63권1호
  • /
  • Pages.83-87
  • /
  • 2007
  • /
  • 1738-3536(pISSN)
  • /
  • 2005-6184(eISSN)
대한결핵및호흡기학회 (The Korean Academy of Tuberculosis and Respiratory Diseases)
권호 표지

폐선암과 병발한 비특이적간질성폐렴 1례

A Case of Non-Specific Interstitial Pneumonia Associated with Primary Lung Adenocarcinoma

  • 심윤수 (이화여자대학교 의학전문대학원 내과학교실) ;
  • 이진화 (이화여자대학교 의학전문대학원 내과학교실) ;
  • 류연주 (이화여자대학교 의학전문대학원 내과학교실) ;
  • 천은미 (이화여자대학교 의학전문대학원 내과학교실) ;
  • 김유경 (이화여자대학교 의학전문대학원 방사선과학교실) ;
  • 성순희 (이화여자대학교 의학전문대학원 병리학교실) ;
  • 안재호 (이화여자대학교 의학전문대학원 흉부외과학교실) ;
  • 장중현 (이화여자대학교 의학전문대학원 내과학교실)
  • Sim, Yun Su (Department of Internal Medicine, Ewha Womans University School of Medicine) ;
  • Lee, Jin Hwa (Department of Internal Medicine, Ewha Womans University School of Medicine) ;
  • Ryu, Yon Ju (Department of Internal Medicine, Ewha Womans University School of Medicine) ;
  • Chun, En Mi (Department of Internal Medicine, Ewha Womans University School of Medicine) ;
  • Kim, Yoo Kyung (Department of Radiology, Ewha Womans University School of Medicine) ;
  • Sung, Sun Hee (Department of Pathology, Ewha Womans University School of Medicine) ;
  • Ahn, Jae Ho (Department of Thoracic Surgery, Ewha Womans University School of Medicine) ;
  • Chang, Jung Hyun (Department of Internal Medicine, Ewha Womans University School of Medicine)
  • 투고 : 2007.05.03
  • 심사 : 2007.06.05
  • 발행 : 2007.07.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

원발폐암과 특발성폐섬유화증(idiopathic pulmonary fibrosis)이 병발하는 경우는 비교적 흔하여, 폐암의 발생률이 일반 인구보다 특발성폐섬유화증 환자에서 더 높다고 알려져 있으나, 비특이적간질성폐렴(non-specific interstitial pneumonia)이 원발폐암과 병발한 경우는 매우 드물다. 이에 저자 등은 최근에 우연히 발견된 원발폐암과 병발한 비특이적간질성폐렴 환자에서 원발폐암의 치료 후에 비특이적간질성폐렴이 저절로 호전된 예를 경험하였기에 보고하는 바이다.

Idiopathic pulmonary fibrosis (IPF) is strongly associated with lung cancer compared with the general population. However, other types of idiopathic interstitial pneumonia (IIP) are rarely associated with lung cancer. We describe a case of a primary lung cancer associated with IIP other than IPF, which was considered to be nonspecific interstitial pneumonia (NSIP), and NSIP disappeared spontaneously after treating the primary lung cancer.

키워드

참고문헌

  1. Matsushita H, Tanaka S, Saiki Y, Hara M, Nakata K, Tanimura S, et al. Lung cancer associated with usual interstitial pneumonia. Pathol Int 1995;45:925-32 https://doi.org/10.1111/j.1440-1827.1995.tb03417.x
  2. Park J, Kim DS, Shim TS, Lim CM, Koh Y, Lee SD, et al. Lung cancer in patients with idiopathic pulmonary fibrosis. Eur Respir J 2001;17:1216-9 https://doi.org/10.1183/09031936.01.99055301
  3. Daniels CE, Jett JR. Does interstitial lung disease predispose to lung cancer? Curr Opin Pulm Med 2005;11:431-7 https://doi.org/10.1097/01.mcp.0000170521.71497.ba
  4. Yamadori I, Sato T, Fujita J, Dobashi N, Ohtsuki Y, Takahara J. A case of non-specific interstitial pneumonia associated with primary lung cancer: possible role of antibodies to lung cancer cells in the pathogenesis of non-specific interstitial pneumonia. Respir Med 1999;93:754-6 https://doi.org/10.1016/S0954-6111(99)90045-8
  5. Sato T, Yamadori I, Fujita J, Hamada N, Yonei T, Bandoh S, et al. Three cases of non-specific interstitial pneumonia associated with primary lung cancer. Intern Med 2004;43:721-6 https://doi.org/10.2169/internalmedicine.43.721
  6. Katzenstein AL, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994;18:136-47 https://doi.org/10.1097/00000478-199402000-00003
  7. Reyes LJ, Morell F, Xaubet A, Ramirez J, Majo J. Nonspecific interstitial pneumonia: epidemiologic and clinical characteristics. Med Clin 2006;126:47-52
  8. Patel AM, Davila DG, Peters SG. Paraneoplastic syndromes associated with lung cancer. Mayo Clin Proc 1993;68:278-87
  9. Bandoh S, Fujita J, Haba R, Tojo Y, Horiike A, Okamoto T, et al. Lung cancer with focal lymphocytic interstitial pneumonia. Intern Med 2002;41:997-1001 https://doi.org/10.2169/internalmedicine.41.997
  10. Takanami I, Takeuchi K, Giga M The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma. J Thorac Cardiovasc Surg 2001;121:1058-63 https://doi.org/10.1067/mtc.2001.113026
  11. Lee TK, Horner RD, Silverman JF, Chen YH, Jenny C, Searantino CW. Morphometric and morphologic evaluations in stage III non-small cell lung cancers. Prognostic significance of quantitative assessment of infiltrating lymphoid cells. Cancer 1989;63:300-16
  12. Lipford EH 3rd, Eggleston JC, Lillemoe KD, Sears DL, Moore GW, Baker RR. Prognostic factors in surgically resected limited-stage, nonsmall cell carcinoma of the lung. Am J Surg Pathol 1984;8:357-65 https://doi.org/10.1097/00000478-198405000-00004
  13. Brittenden J, Beys SD, Ross J, Eremin O. Natural killer cells and cancer. Cancer 1996;77:1226-43 https://doi.org/10.1002/(SICI)1097-0142(19960401)77:7<1226::AID-CNCR2>3.0.CO;2-G
  14. Johnson SK, Kerr KM, Chapman AD, Kennedy MM, King G, Cockburn JS, et al. Immune cell infiltrates and prognosisin primary carcinoma of the lung. Lung Cancer 2000;27:27-35 https://doi.org/10.1016/S0169-5002(99)00095-1
  15. Watanabe S, Sato Y, Kodama T, Shimosato Y. Immunohistochemical study with monoclonal antibodies on immune response in human lung cancers. Cancer Res 1983;43:5883-9